Skip to main content
. 2021 Nov 24;100(47):e27952. doi: 10.1097/MD.0000000000027952

Figure 2.

Figure 2

Cumulative percentage of children who received palivizumab and the number of RSV-related hospitalizations by month. The blue bars show the cumulative percentage of children who received palivizumab. The gray bars show the percentage of children who did not receive palivizumab. The line graph shows the number of RSV-related hospitalizations. RSV = respiratory syncytial virus.